Acute Health Effects of Low Temperature Exposure
1 other identifier
interventional
50
1 country
1
Brief Summary
This is a randomized controlled human exposure crossover study. Investigators aims to assess the acute effects of low temperature exposure and the underlying mechanisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2023
CompletedStudy Start
First participant enrolled
October 10, 2023
CompletedFirst Posted
Study publicly available on registry
October 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedOctober 11, 2023
October 1, 2023
1 month
September 8, 2023
October 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Heart Rate Variability Parameters
Investigators plan to measure heart rate variability (HRV) parameters (e.g., SDNN, PNN50, LF, HF)
Volunteers will be asked to wear electrographic Holter monitors for 24 hours from 1:00 P.M. at the day of intervention to 1:00 P.M. at the next day.
Blood Pressure
The changes of systolic blood pressure (SBP) and diastolic blood pressure (DBP) will be measured.
Blood pressure will be examined before exposure and immediately after the exposure session
Forced vital capacity
Investigators plan to measure forced vital capacity (FVC) by spirometry
Lung function will be examined before exposure and half an hour after the exposure session
Forced expiratory volume in one second
Investigators plan to measure forced expiratory volume in one second (FEV1) by spirometry.
Lung function will be examined before exposure and half an hour after the exposure session
Maximal mid-expiratory flow
Investigators plan to measure maximal mid-expiratory flow (MMEF) by spirometry.
Lung function will be examined before exposure and half an hour after the exposure session
Results of Stroop Tests
Investigators plan to measure the changes of cognitive function using Stroop Test.
The tests will be conducted before exposure and immediately after the exposure session
Secondary Outcomes (5)
Changes of skin temperature
Skin temperature will be examined from 1:00 P.M. to 4:30 P.M. at the day of intervention
Results of simple reaction time
Simple reaction time will be examined before exposure and immediately after the exposure session
Results of visual memory
Visual memory will be examined before exposure and immediately after the exposure session
Activated brain regions demonstrating brain activity related to the low temperature exposure
MRI will be examined 1 hour after the exposure session
Changes in cerebral hemodynamics demonstrating brain activity related to the low temperature exposure
fNIRS will be examined before exposure and immediately after the exposure session
Other Outcomes (7)
Differences in metabolites detected in blood between the two exposures
Blood will be collected 1 hour after the exposure session
Differences in protein levels detected in blood between the two exposures
Blood will be collected 1 hour after the exposure session
Differences in DNA methylation levels detected in whole-blood between the two exposures
Blood will be collected 1 hour after the exposure session
- +4 more other outcomes
Study Arms (2)
Low temperature (16#) group
EXPERIMENTALSubjects in exposure group will be exposed to low temperature (16#) for about 2 hours in a chamber.
Moderate temperature (22#) group
SHAM COMPARATORSubjects in exposure group will be exposed to moderate temperature (22#) for about 2 hours in a chamber.
Interventions
The exposure group will be exposed to low temperature (16#) in a chamber for about 2 hours, resting during the whole periods.
The exposure group will be exposed to thermoneutral temperature (22#) in a chamber for about 2 hours, resting during the whole periods.
Eligibility Criteria
You may qualify if:
- Living in Shanghai during the study period;
- Body mass index \> 18.5 and ≤ 28;
- Right-handed;
- Receiving or having received higher education;
- With the ability to read and understand Chinese smoothly.
You may not qualify if:
- Smoking and alcohol abuse;
- Current drug and dietary supplements intake;
- Subjects with allergic diseases, such as allergic rhinitis, allergic asthma, and atopy;
- Subjects with cardiovascular diseases, such as congenital heart disease, pulmonary heart disease, and hypertension;
- Subjects with respiratory diseases, such as asthma, chronic bronchitis, and chronic obstructive pulmonary disease;
- Subjects with chronic diseases, such as diabetes, chronic hepatitis, and kidney disease;
- Subjects who have a history of major surgery due to cardiovascular, cerebrovascular, respiratory, or neurological diseases;
- Subjects with neurologic disorders, such as stroke, traumatic brain injury, epilepsy, and schizophrenia;
- Abnormal spirometry (FEV1 and FVC ≤ 75% of predicted and FEV1/FVC ≤ 0.65);
- Subjects with color vision disabilities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
Study Sites (1)
Department of Environmental Health, School of Public Health, Fudan University
Shanghai, Shanghai Municipality, 200032, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Haidong Kan, PhD
Department of Environmental Health, School of Public Health, Fudan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 8, 2023
First Posted
October 11, 2023
Study Start
October 10, 2023
Primary Completion
November 15, 2023
Study Completion
December 31, 2024
Last Updated
October 11, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share